# The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes

> **NCT06426823** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Blood Flow

## Interventions

- **OTHER:** Saline / placebo
- **OTHER:** GIPR antagonist / study tool

## Key facts

- **NCT ID:** NCT06426823
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2026-03-16
- **Final completion:** 2026-03-16
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426823, "The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06426823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*